The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as ...

The Greater Philadelphia life sciences ecosystem has over 1,200 life sciences establishments, including 450 biotech research ...

Drugmaker Regeneron has plans to adapt the former Quad plant in Saratoga Springs for manufacturing.

WATCH: Behind the scenes of big ticket litigation — lessons from the courts ...

In this video, Jonathan A. Bernstein, MD, discusses an American College of Allergy, Asthma & Immunology Annual Scientific ...

It's full steam ahead for a new Regeneron facility in Saratoga Springs. The company has learned that Saratoga County's ...

Pharma marketers are still getting up to speed on the changing health data privacy landscape. Here’s how they can develop ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is initiating a Phase 2 study ...

Several headwinds have pushed Regeneron 's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is bouncing back and has performed well in recent months. What's more, there ...

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli Lilly's experimental weight‑loss pill, after the company pushed for a faster ...